Brima M. Younis

Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study

Ahmed Musa, Brima M. Younis, Ahmed Fadlalla et al. · PLoS neglected tropical diseases · 2010 · 117 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial

Eltahir Awad Gasim Khalil, Teklu Weldegebreal, Brima M. Younis et al. · PLoS neglected tropical diseases · 2014 · 100 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Safety and Efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial

Raymond Omollo, Neâl Alexander, Tansy Edwards et al. · Trials · 2011 · 71 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +16

Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial

Ahmed Musa, Jane Mbui, Rezika Mohammed et al. · Clinical Infectious Diseases · 2022 · 71 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan

Brima M. Younis, Mohamed Osman, Eltahir Awad Gasim Khalil et al. · Molecular Therapy · 2021 · 66 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17